Health Care Equipment and Supplies Health Care Equipment

  • WARSAW, Indiana/ WASHINGTON, Dec 9- When Donald Trump takes over as president on Jan. 20, one of the first business tax breaks he delivers is likely to go to the U.S. medical device industry and companies like Mark Throdahl's. The chief executive of OrthoPediatrics Corp, based in northern Indiana, said his company has been able to hire more workers since the temporary...

  • Although legal experts think J&J faces an uphill battle, both they and investors believe the Texas jury's penalty, the largest product liability verdict so far this year, is unlikely to stand. It is the second large verdict against J&J in the Pinnacle implant litigation, which has been consolidated before U.S. District Court Judge Edward Kinkeade in Texas.

  • BEIJING— Medical device maker Medtronic has been fined $17 million by Chinese anti-monopoly regulators in the latest effort by Beijing to force down what it sees as unreasonably high prices. Regulators concluded Medtronic, which supplies cardiovascular, restorative, and diabetes-related medical devices, suppressed competition by enforcing minimum...

  • Dec 2- A federal appeals court on Friday threw out an antitrust verdict that ordered medical device maker Becton Dickinson and Co to pay rival Retractable Technologies Inc $340 million in damages over its marketing of safety syringes. The 5th U.S. Circuit Court of Appeals in New Orleans called Retractable's claim that Becton violated the Sherman Act by trying...

  • PARIS, Dec 1- Shares in artificial heart maker Carmat fell more than 13 percent on Thursday after France's national drugs agency ordered it to suspend further implants in a second test phase following the death of a patient in October. Carmat shares were down by 13.19 percent at 29.01 euros in end-session trading, wiping some 26 million euros off the company's...

  • PARIS, Dec 1- Shares in artificial heart maker Carmat slumped on Thursday after France's national drugs agency ordered it to suspend further implants following the death of a patient in October. Carmat shares were down by 12.4 percent at 29.55 euros in mid-session trading, wiping some 26 million euros off the company's stock market value.

  • PARIS, Dec 1- Shares in artificial heart maker Carmat slumped on Thursday after France's national drugs agency ordered it to suspend further implants following the death of a patient in October. Carmat shares were down by 18.5 percent at 27.50 euros in morning trading, with around 40 million euros wiped off its stock market value. Carmat Chief Executive...

  • PARIS, Nov 30- France's national drugs agency said on Wednesday it had ordered artificial heart maker Carmat to suspend further implants after a fifth patient died in October. A spokeswoman for the drugs agency said that it had requested further information from the company following the patient's death, which was first reported by Europe 1 radio.

  • But their objections were overwhelmed by an alliance among Republicans, many Democrats and the White House for a 996- page measure that bore wins for both parties. The Senate's expected final approval next week would mark an uncommon episode of cooperation between the GOP- run 114th Congress— which plans to adjourn next week— and President Barack Obama in their...

  • Revenue at Medtronic's diabetes unit rose 3 percent to $462 million in the second quarter ended Oct. 28. MiniMed 670 G- the first device that allows a glucose sensor to communicate with an insulin pump and automatically regulate insulin flow- was approved by the U.S. Food and Drug Administration in September and is expected to launch in spring 2017..

  • *Qtrly revenue $7.35 bln vs. est. Sales in its cardiac and vascular unit, where Medtronic sells defibrillators, pacemakers, heart valves and stents, were $2.58 billion in the second quarter ended Oct. 28, below analysts' average estimate of $2.64 billion, compiled by Evercore ISI. MiniMed 670 G was approved by the U.S. Food and Drug Administration in September and is...

  • Nov 22- Medtronic Plc, the world's largest standalone medical device maker, reported a 4 percent rise in quarterly revenue, helped by higher demand for its minimally invasive devices and heart products. The company's net income rose to $1.11 billion, or 80 cents per share, in the second quarter ended Oct. 28 from $520 million, or 36 cents per share, a year earlier.

  • Oct 28- Medical device maker St. Jude Medical Inc said on Friday it has notified doctors to stop implants of one of its cardiac pacemakers, citing reports of problems with electronic data reporting caused by a battery malfunction that could put patients at risk. Jude Chief Medical Officer Mark Carlson said in a statement, adding that the company remains...

  • The company reported a net profit of $228 million, or 17 cents per share, in the third quarter ended Sept. 30. That compared with a loss of $198 million, or 15 cents per share, a year earlier, largely due to litigation charges. Net sales rose to $2.11 billion from $1.89 billion.

  • Oct 25- Edwards Lifesciences Corp on Tuesday reported third quarter sales of its minimally invasive heart valve replacements that fell short of Wall Street estimates, and its previously high-flying shares plunged more than 14 percent. Global transcatheter heart valve therapy sales jumped 38.5 percent to $410.1 million, missing analysts' consensus...

  • Oct 25- Edwards Lifesciences Corp on Tuesday reported third quarter sales of its critically important minimally invasive heart valve replacements that fell short of Wall Street estimates, and its previously high-flying shares plunged nearly 20 percent. Edwards shares, which had been up about 44 percent year-to-date, making it one of the best performers in...

  • FDA STATEMENT ADVISES PATIENTS WITH ST JUDE HEART IMPLANTS TO CONTINUE TO USE DEVICES AS DIRECTED BY DOCTORS.

  • Hacking health care

    CNBC's Landon Dowdy looks into the cybersecurity of medical devices.

  • NEW YORK, Oct 20- Bullish options on Varian Medical Systems Inc stock saw unusually heavy buying on Thursday before the shares spiked on an unsubstantiated report that General Electric could be in talks with the medical devices company about a possible takeover. Roughly 2,100 Varian Medical Systems call contracts betting on the shares rising above $100 by...

  • Jude by the end of the year and praised the smaller company's handling of claims by short-seller Muddy Waters that its implantable heart devices posed cyber security risks. Shares of Abbott fell 2.7 percent to $40.04 while Alere rose 2.3 percent to $43.36 and St. Jude dipped 0.6 percent to $79, all on the New York Stock Exchange.